All Stories

  1. Correction: Vernia et al. Immunoglobulin G4-Related Disease of the Intestine: A Clinicopathological Entity to Be Considered. Medicina 2024, 60, 57

    Article • Medicina, March 2026, MDPI AG

    Researcher angelo viscido

  2. The Relationship Between Nutritional Status, Micronutrient Deficiency, and Disease Activity in IBD Patients: A Multicenter Cross-Sectional Study

    Article • Nutrients, August 2025, MDPI AG

    Researcher angelo viscido

  3. Inter-rater Reliability and Accuracy of NBI Score for Activity Evaluation in Ulcerative Colitis

    Article • Reviews on Recent Clinical Trials, July 2025, Bentham Science Publishers

    Researcher angelo viscido, Michele Marchese

  4. Inflammatory Bowel Disease in the Post-STRIDE II Era: Epidemiology and Long-Term Clinical Outcomes from a Population-Based Study

    Article • Medical Sciences, May 2025, MDPI AG

    Researcher angelo viscido

  5. Inflammatory Bowel Disease in the Post-STRIDE II Era: Epidemiology and Long-term Clinical Outcomes from a Population-Based Study

    Article • April 2025, MDPI AG

    Researcher angelo viscido

  6. Immunoglobulin G4-Related Disease of the Intestine: A Clinicopathological Entity to Be Considered

    Article • Medicina, December 2023, MDPI AG

    Researcher angelo viscido

  7. COVID-19 and Gastrointestinal Tract: From Pathophysiology to Clinical Manifestations

    Article • Medicina, September 2023, MDPI AG

    Researcher angelo viscido

  8. Nutrition, Nutritional Status, Micronutrients Deficiency, and Disease Course of Inflammatory Bowel Disease

    Article • Nutrients, August 2023, MDPI AG

    Researcher angelo viscido

  9. Prophylactic Treatment with Vedolizumab in the Prevention of Postoperative Recurrence (POR) in High-Risk Crohn’s Patients

    Article • Journal of Clinical Medicine, April 2023, MDPI AG

    Researcher angelo viscido

  10. Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis

    Article • BMC Gastroenterology, March 2022, Springer Science + Business Media

    Researcher angelo viscido

  11. Non-steroidal anti-inflammatory drugs and acetylsalicylic acid increase the risk of complications of diverticular disease: a meta-analysis of case–control and cohort studies

    Article • International Journal of Colorectal Disease, January 2022, Springer Science + Business Media

    Researcher angelo viscido

  12. Vitamin D in Inflammatory Bowel Diseases. Mechanisms of Action and Therapeutic Implications

    Article • Nutrients, January 2022, MDPI AG

    Researcher angelo viscido

  13. Pericarditis after SARS-CoV-2 Infection: Another Pebble in the Mosaic of Long COVID?

    Article • Viruses, October 2021, MDPI AG

    Researcher angelo viscido

  14. Are Volatile Organic Compounds Accurate Markers in the Assessment of Colorectal Cancer and Inflammatory Bowel Diseases? A Review

    Article • Cancers, May 2021, MDPI AG

    Researcher angelo viscido

  15. Association of Colonic Diverticula with Colorectal Adenomas and Cancer

    Article • Medicina, January 2021, MDPI AG

    Researcher angelo viscido

  16. The Usefulness of Serum Vitamin D Levels in the Assessment of IBD Activity and Response to Biologics

    Article • Nutrients, January 2021, MDPI AG

    Researcher angelo viscido

  17. Inflammatory Bowel Disease: New Insights into the Interplay between Environmental Factors and PPARγ

    Article • International Journal of Molecular Sciences, January 2021, MDPI AG

    Researcher angelo viscido

  18. Dietary Factors Modulating Colorectal Carcinogenesis

    Article • Nutrients, January 2021, MDPI AG

    Researcher angelo viscido

  19. Association between Corrected QT Interval and C-Reactive Protein in Patients with Inflammatory Bowel Diseases

    Article • Medicina, July 2020, MDPI AG

    Researcher angelo viscido

  20. Could Pirfenidone Also be Effective in Treating Intestinal Fibrosis?

    Article • Cells, July 2020, MDPI AG

    Researcher angelo viscido

  21. Persistent Iron Deficiency Anemia in Patients with Celiac Disease Despite a Gluten-Free Diet

    Article • Nutrients, July 2020, MDPI AG

    Researcher angelo viscido

  22. Non-medical Switching of Infliximab to CT-P13 Biosimilar in Inflammatory Bowel Disease: A Focus on the Definition of “Non-medical Switch”

    Article • Digestive Diseases and Sciences, June 2020, Springer Science + Business Media

    Researcher angelo viscido

  23. Topography, morphology, and etiology of lymphocytic gastritis: a focus on celiac disease

    Article • Virchows Archiv, May 2020, Springer Science + Business Media

    Researcher angelo viscido

  24. Food Allergy Insights: A Changing Landscape

    Article • Archivum Immunologiae et Therapiae Experimentalis, April 2020, Springer Science + Business Media

    Researcher angelo viscido

  25. Celiac Disease, Gluten-Free Diet, and Metabolic and Liver Disorders

    Article • Nutrients, March 2020, MDPI AG

    Researcher angelo viscido

  26. Controversial Contribution of Th17/IL-17 Toward the Immune Response in Intestinal Fibrosis

    Article • Digestive Diseases and Sciences, March 2020, Springer Science + Business Media

    Researcher angelo viscido

  27. Is fecal calprotectin an accurate marker in the management of Crohn's disease?

    Article • Journal of Gastroenterology and Hepatology, December 2019, Wiley

    Researcher angelo viscido

  28. Topical Aminosalicylates and Histologic Healing in Ulcerative Colitis

    Article • The American Journal of Gastroenterology, December 2019, Wolters Kluwer Health

    Researcher angelo viscido

  29. Food Allergies and Ageing

    Article • International Journal of Molecular Sciences, November 2019, MDPI AG

    MASSIMO DE MARTINIS, Researcher angelo viscido

  30. Unmet Medical Needs in the Management of Ulcerative Colitis: Results of an Italian Delphi Consensus

    Article • Gastroenterology Research and Practice, September 2019, Hindawi Publishing Corporation

    Researcher angelo viscido

  31. Can Nrf2 Modulate the Development of Intestinal Fibrosis and Cancer in Inflammatory Bowel Disease?

    Article • International Journal of Molecular Sciences, August 2019, MDPI AG

    Researcher angelo viscido

  32. Wegener’s granulomatosis and retroperitoneal fibrosis: a case report and review of the literature

    Article • Italian Journal of Medicine, June 2019, PAGEPress Publications

    Researcher angelo viscido

  33. Duodenal lymphocytosis in functional dyspepsia

    Article • Arab Journal of Gastroenterology, June 2019, Elsevier

    Researcher angelo viscido

  34. Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)

    Article • Digestive and Liver Disease, May 2019, Elsevier

    Researcher angelo viscido

  35. L’importanza del coinvolgimento attivo del paziente nella gestione delle malattie infiammatorie croniche dell’intestino

    Article • Recenti Progressi in Medicina, May 2019, Il Pensiero Scientifico Editore

    Researcher angelo viscido

  36. Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?

    Article • Biologics Targets and Therapy, April 2019, Dove Medical Press

    Giovanni Latella, Researcher angelo viscido

  37. Metabolic Alterations in Celiac Disease Occurring after Following a Gluten-Free Diet

    Article • Digestion, December 2018, Karger Publishers

    Researcher angelo viscido

  38. Mesalazine treatment in organotypic culture of celiac patients: Comparative study with gluten free diet

    Article • Journal of Cellular Physiology, January 2018, Wiley

    Researcher angelo viscido

  39. The prognostic value of histology in ulcerative colitis in clinical remission with mesalazine

    Article • Therapeutic Advances in Gastroenterology, August 2017, SAGE Publications

    Researcher angelo viscido

  40. Mastocytic enterocolitis: Increase of mast cells in the gastrointestinal tract of patients with chronic diarrhea

    Article • Gastroenterología y Hepatología, August 2017, Elsevier

    Researcher angelo viscido

  41. Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)

    Article • Digestive and Liver Disease, April 2017, Elsevier

    Researcher angelo viscido

  42. Subtypes of chronic gastritis in patients with celiac disease before and after gluten-free diet

    Article • United European Gastroenterology Journal, January 2017, SAGE Publications

    Giovanni Latella, Researcher angelo viscido

  43. Effects of Exercise Training on Delaying Disease Progression in Patients with Chronic Kidney Disease: a Review of the Literature

    Article • Reviews on Recent Clinical Trials, October 2016, Bentham Science Publishers

    Researcher angelo viscido

  44. Non-Celiac Gluten Sensitivity among Patients Perceiving Gluten-Related Symptoms

    Article • Digestion, January 2015, Karger Publishers

    Researcher angelo viscido

  45. Nanotechnology in the treatment of inflammatory bowel diseases

    Article • Journal of Crohn s and Colitis, September 2014, Oxford University Press (OUP)

    Researcher angelo viscido

  46. Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy

    Article • Journal of Crohn s and Colitis, August 2014, Oxford University Press (OUP)

    Researcher angelo viscido

  47. Predictive factors of clinical response in steroid-refractory ulcerative colitis treated with granulocyte-monocyte apheresis

    Article • World Journal of Gastroenterology, January 2011, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Researcher angelo viscido

  48. Mesalazine vanishing time from rectal mucosa following its topical administration

    Article • Journal of Crohn s and Colitis, February 2010, Oxford University Press (OUP)

    Researcher angelo viscido

  49. Clinical course of Crohn’s disease first diagnosed at surgery for acute abdomen

    Article • Digestive and Liver Disease, April 2009, Elsevier

    Researcher angelo viscido

  50. Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFα therapy

    Article • Journal of Clinical Virology, October 2008, Elsevier

    Researcher angelo viscido

  51. Safe use of infliximab for the treatment of fistulizing Crohnʼs disease during pregnancy within 3 months of conception

    Article • Inflammatory Bowel Diseases, March 2008, Oxford University Press (OUP)

    Researcher angelo viscido

  52. Early versus late surgery for ileo-caecal Crohn’s disease

    Article • Alimentary Pharmacology & Therapeutics, November 2007, Wiley

    Researcher angelo viscido

  53. Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases

    Article • Inflammatory Bowel Diseases, October 2007, Oxford University Press (OUP)

    Researcher angelo viscido

  54. Another paradox in Crohnʼs disease: New onset of psoriasis in a patient receiving tumor necrosis factor-α antagonist

    Article • Inflammatory Bowel Diseases, August 2007, Oxford University Press (OUP)

    Researcher angelo viscido

  55. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up

    Article • Alimentary Pharmacology & Therapeutics, June 2007, Wiley

    Researcher angelo viscido

  56. Current management of severe ulcerative colitis

    Article • Nature Clinical Practice Gastroenterology &#38 Hepatology, February 2007, Springer Science + Business Media

    Researcher angelo viscido

  57. Mucosal features and granulocyte–monocyte-apheresis in steroid-dependent/refractory ulcerative colitis

    Article • Digestive and Liver Disease, June 2006, Elsevier

    Researcher angelo viscido

  58. Seasonal variations in onset of symptoms in Crohn's disease

    Article • Digestive and Liver Disease, May 2006, Elsevier

    Researcher angelo viscido

  59. Ferritin as a simple indicator of iron deficiency in anemic IBD patients

    Article • Inflammatory Bowel Diseases, February 2006, Oxford University Press (OUP)

    Researcher angelo viscido

  60. MR Imaging in Patients with Crohn Disease: Value of T2- versus T1-weighted Gadolinium-enhanced MR Sequences with Use of an Oral Superparamagnetic Contrast Agent

    Article • Radiology, February 2006, Radiological Society of North America (RSNA)

    Researcher angelo viscido

  61. Increased risk of breast cancer in first-degree relatives of Crohn's disease patientsAn IG-IBD study

    Article • Digestive and Liver Disease, January 2006, Elsevier

    Researcher angelo viscido

  62. Infliximab in the treatment of Crohn's disease: Predictors of response in an Italian multicentric open study

    Article • Digestive and Liver Disease, August 2005, Elsevier

    Researcher angelo viscido

  63. Two synchronous adenocarcinomas of the small bowel in a patient with undiagnosed Crohn's disease of the terminal ileum

    Article • International Journal of Colorectal Disease, July 2005, Springer Science + Business Media

    Simone Sibio, Researcher angelo viscido

  64. Inflammatory bowel diseases: clinical update of practical guidelines

    Article • Nuclear Medicine Communications, July 2005, Wolters Kluwer Health

    Alberto Signore, Researcher angelo viscido

  65. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement

    Article • Digestive and Liver Disease, June 2005, Elsevier

    Researcher angelo viscido

  66. A New Oral Delivery System for 5-ASA: Preliminary Clinical Findings for MMX

    Article • Inflammatory Bowel Diseases, May 2005, Oxford University Press (OUP)

    Researcher angelo viscido

  67. Small Intestine Contrast Ultrasonography

    Article • Inflammatory Bowel Diseases, February 2005, Oxford University Press (OUP)

    Researcher angelo viscido

  68. Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations

    Article • Annals of the Rheumatic Diseases, December 2004, BMJ

    Researcher angelo viscido

  69. Efficacy of conventional immunosuppressive drugs in IBD

    Article • Digestive and Liver Disease, November 2004, Elsevier

    Researcher angelo viscido

  70. Development of Fistulae in Ileo-Anal Pouch does not Necessarily Indicate Crohn's Disease

    Article • The American Journal of Gastroenterology, October 2004, Wolters Kluwer Health

    Researcher angelo viscido

  71. Infliximab and quality of life in steroid-dependent Crohn’s disease

    Article • Digestive and Liver Disease, August 2004, Elsevier

    Researcher angelo viscido

  72. An unusual treatment for a colonic polyp

    Article • Gut, July 2004, BMJ

    Researcher angelo viscido

  73. Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidence

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2004, De Gruyter

    Researcher angelo viscido

  74. Infliximab in refractory pouchitis complicated by fistulae following ileo-anal pouch for ulcerative colitis

    Article • Alimentary Pharmacology & Therapeutics, May 2003, Wiley

    Researcher angelo viscido

  75. Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial

    Article • Alimentary Pharmacology & Therapeutics, February 2003, Wiley

    Researcher angelo viscido

  76. Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon

    Article • International Journal of Colorectal Disease, January 2003, Springer Science + Business Media

    Researcher angelo viscido

  77. Biological agents in the treatment of Crohn's disease

    Article • Alimentary Pharmacology & Therapeutics, September 2002, Wiley

    Researcher angelo viscido

  78. MRI evaluation of Crohn's disease of the small and large bowel with the use of negative superparamagnetic oral contrast agents

    Article • Abdominal Imaging, July 2002, Springer Science + Business Media

    Researcher angelo viscido

  79. GI distension in severe ulcerative colitis

    Article • The American Journal of Gastroenterology, May 2002, Wolters Kluwer Health

    Researcher angelo viscido

  80. Survival and causes of death in Italian patients with ulcerative colitis A GISC nation-wide study

    Article • Digestive and Liver Disease, November 2001, Elsevier

    Researcher angelo viscido

  81. Evaluation of Crohn disease activity with magnetic resonance imaging

    Article • Abdominal Imaging, March 2000, Springer Science + Business Media

    Researcher angelo viscido

  82. Rectal and colonic mesalazine concentration in ulcerative colitis: oral vs. oral plus topical treatment

    Article • Alimentary Pharmacology & Therapeutics, November 1999, Wiley

    Researcher angelo viscido

  83. Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Cooperative Investigators of the Italian Group for the Study of the Colon and the Rectum (GISC)

    Article • International Journal of Epidemiology, June 1998, Oxford University Press (OUP)

    Researcher angelo viscido

  84. Prognostic factors for postoperative recurrence of Crohnʼs disease

    Article • Diseases of the Colon & Rectum, March 1996, Wolters Kluwer Health

    Researcher angelo viscido